Delivery Order SPE2DB20D3303-SPE2DB25FA0MU
Award Date
6/20/25
Potential Completion Date
6/23/25
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $36,865.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product, with a period of performance through May 13, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,195.01, is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award value of $7,770.14 and an ultimate completion date of March 31, 2025. It is a delivery order contract for the pharmaceutical product RYTARY ER 36.25 MG-145 MG CAP 100S, with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, with a ceiling value of $13,281.77 and a period of performance through April 28, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,494.92, is a Firm Fixed Price Delivery Order for the pharmaceutical product RYTARY ER 48.75 MG-195 MG CAP 100S. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,985.36 firm fixed-price delivery order covers the supply of RYTARY ER 36.25 MG-145 MG capsules in 100-count packages. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,325.53 firm fixed-price contract is for the supply of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award, valued at $7,330.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, over a period ending on May 9, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rytary ER 36.25 MG-145 MG capsules, with a ceiling value of $3,479.30. The contract is a firm fixed price, non-set-aside delivery order with a performance period through May 7, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,537.04, is for the delivery of RYTARY ER 61.25 MG-245 MG capsules. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...